AbbVie Hails Humira’s Resistance To US Competition

Adalimumab Originator Does Better Than Expected Against Biosimilar Pressure In Q2

 
• By David Wallace
Abstract image of man pushing back against dominoes
Humira is standing up to biosimilar competition • Source: Shutterstock

More from Biosimilars

More from Products